Literature DB >> 25341697

The weaned pig as a model for Doxorubicin-induced mucositis.

Jamee Martin1, Scott C Howard, Asha Pillai, Peter Vogel, Anjaparavanda P Naren, Steven Davis, Karen Ringwald-Smith, Karyl Buddington, Randal K Buddington.   

Abstract

BACKGROUND: Chemotherapy-induced mucositis (CIM) complicates cancer therapy and limits maximum tolerated doses and efficacy. Rodent models do not reproducibly mimic clinical CIM, so alternative models are needed.
METHODS: CIM severity was assessed after weaned pigs were treated with doxorubicin (5 and 3.75 mg/kg) using clinical observations, laboratory parameters and gastrointestinal structure and functions. Bovine colostrum was provided as an experimental intervention to the pigs treated receiving the 3.75 mg/kg dose.
RESULTS: Doxorubin at 3.75 mg/kg decreased food intake and weight gain (p < 0.05) and caused diarrhea and vomiting that coincided with damage to the small intestine mucosa based on histological scoring (p < 0.05). It resulted in higher serum TNF-α concentrations, increased chloride secretion and reduced brush border membrane disaccharidase activities and carrier-mediated glucose uptake (all p < 0.05). The gastrointestinal damage and dysfunction resemble the clinical and laboratory features of CIM in humans; these can be partially prevented by providing cow colostrum.
CONCLUSION: The weaned pig is a relevant large animal for studying CIM and evaluating existing and experimental interventions for mucositis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25341697      PMCID: PMC7762628          DOI: 10.1159/000365725

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  55 in total

Review 1.  Interventions for preventing oral mucositis for patients with cancer receiving treatment.

Authors:  Helen V Worthington; Jan E Clarkson; Gemma Bryan; Susan Furness; Anne-Marie Glenny; Anne Littlewood; Martin G McCabe; Stefan Meyer; Tasneem Khalid
Journal:  Cochrane Database Syst Rev       Date:  2011-04-13

Review 2.  Chemotherapy-induced diarrhoea.

Authors:  Rachel J Gibson; Andrea M Stringer
Journal:  Curr Opin Support Palliat Care       Date:  2009-03       Impact factor: 2.302

3.  Purification of the human intestinal brush border membrane.

Authors:  J Schmitz; H Preiser; D Maestracci; B K Ghosh; J J Cerda; R K Crane
Journal:  Biochim Biophys Acta       Date:  1973-09-27

4.  Non-invasive detection of a palifermin-mediated adaptive response following chemotherapy-induced damage to the distal small intestine of rats.

Authors:  Roger Yazbeck; Gordon S Howarth; Luis Borges; Mark S Geier; Cassie L Smith; Geoffrey P Davidson; Ross N Butler
Journal:  Cancer Biol Ther       Date:  2011-09-01       Impact factor: 4.742

5.  Regulation of the PepT1 peptide transporter in the rat small intestine in response to 5-fluorouracil-induced injury.

Authors:  H Tanaka; K I Miyamoto; K Morita; H Haga; H Segawa; T Shiraga; A Fujioka; T Kouda; Y Taketani; S Hisano; Y Fukui; K Kitagawa; E Takeda
Journal:  Gastroenterology       Date:  1998-04       Impact factor: 22.682

Review 6.  The role of intestinal microbiota in the development and severity of chemotherapy-induced mucositis.

Authors:  Michel J van Vliet; Hermie J M Harmsen; Eveline S J M de Bont; Wim J E Tissing
Journal:  PLoS Pathog       Date:  2010-05-27       Impact factor: 6.823

7.  Milk growth factors enriched from cheese whey ameliorate intestinal damage by methotrexate when administered orally to rats.

Authors:  G S Howarth; G L Francis; J C Cool; X Xu; R W Byard; L C Read
Journal:  J Nutr       Date:  1996-10       Impact factor: 4.798

8.  Role of the cyclooxygenase pathway in chemotherapy-induced oral mucositis: a pilot study.

Authors:  Rajesh V Lalla; Carol C Pilbeam; Stephen J Walsh; Stephen T Sonis; Dorothy M K Keefe; Douglas E Peterson
Journal:  Support Care Cancer       Date:  2009-04-29       Impact factor: 3.603

9.  Regulation of sucrase-isomaltase gene expression in human intestinal epithelial cells by inflammatory cytokines.

Authors:  T Ziambaras; D C Rubin; D H Perlmutter
Journal:  J Biol Chem       Date:  1996-01-12       Impact factor: 5.157

10.  A pig model of the human gastrointestinal tract.

Authors:  Quanshun Zhang; Giovanni Widmer; Saul Tzipori
Journal:  Gut Microbes       Date:  2013-04-02
View more
  4 in total

1.  Varied effects of doxorubicin (DOX) on the corpus luteum of C57BL/6 mice during early pregnancy†.

Authors:  Christian Lee Andersen; Haeyeun Byun; Yuehuan Li; Shuo Xiao; Doris M Miller; Zidao Wang; Suvitha Viswanathan; Jonathan Matthew Hancock; Jaymie Bromfield; Xiaoqin Ye
Journal:  Biol Reprod       Date:  2021-12-20       Impact factor: 4.161

Review 2.  Preventing and Managing Toxicities of High-Dose Methotrexate.

Authors:  Scott C Howard; John McCormick; Ching-Hon Pui; Randall K Buddington; R Donald Harvey
Journal:  Oncologist       Date:  2016-08-05

Review 3.  Potential Benefits of Bovine Colostrum in Pediatric Nutrition and Health.

Authors:  Per Torp Sangild; Caitlin Vonderohe; Valeria Melendez Hebib; Douglas G Burrin
Journal:  Nutrients       Date:  2021-07-26       Impact factor: 5.717

Review 4.  Colostrum Therapy for Human Gastrointestinal Health and Disease.

Authors:  Kanta Chandwe; Paul Kelly
Journal:  Nutrients       Date:  2021-06-07       Impact factor: 5.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.